Medical Devices

As market conditions stabilize and capital begins to re-engage, contract development and manufacturing organizations (CDMOs) are emerging as central drivers of value creation across the MedTech ecosystem. In 2026, the convergence of financial clarity, strategic repositioning, and platform scale ambition is expected to redefine how OEMs and investors approach growth, partnerships, and M&A in the […]

Medtech equities broadly underperformed major market indexes in 2025, pressured by tariff uncertainty and investor rotation toward AI. Diagnostics was a notable exception, delivering a median return of nearly 30%. Despite the sector’s weak performance, M&A and IPOs generated headlines in Q4. Medline completed the largest healthcare IPO on record, signaling some easing of tariff